Phase 3Data readout

IMVT-1402 (FcRn Blocker)

Graves' Disease

ROIVRoivant

Expected catalystDecember 31, 2027Company guidance: Dec 31, 2027

Catalyst overview

Event details

Drug or asset: IMVT-1402 (FcRn Blocker)
Development stage: Phase 3
Event type: Data readout
Indication: Graves' Disease

Research summary

What is being tracked?

This catalyst tracks a Phase 3 data readout for IMVT-1402 (FcRn Blocker) in Graves' Disease. The expected timing is based on the latest available company guidance and may change.

Development notes

04/02/26:- Potentially registrational Graves' disease studies target topline data in 2027.

Verification

Primary source

Confirm timing and program details against the company announcement or filing.

Open source

IMVT-1402 (FcRn Blocker)

Event details

What is being tracked?

Development notes

Primary source

Related pipeline programs

Brepocitinib

Brepocitinib

Brepocitinib

Mosliciguat